BACKGROUND: We describe health care resource utilization among HIV-1-infected children who have not yet undergone antiretroviral treatment (ART) in Abidjan, Côte d'Ivoire. METHODS: HIV-infected children enrolled prospectively in an HIV care programme in 2 health facilities in Abidjan (2004-2009) were followed up from date of inclusion until database closeout, death, ART initiation, or loss to follow-up (no clinical contact for more than 6 months). Incidences of health care resource utilization (outpatient care, inpatient day care, and hospitalization) were described according to severe morbidity and mixed effect log linear models were computed to identify associated factors. RESULTS: Overall, 405 children were included, entering care at a median age of 4.5 years, 66.9% were receiving cotrimoxazole prophylaxis, and 27.7% met 2006 WHO criteria for immunodeficiency by age. The median follow-up time was 11.6 months (interquartile range: 1.4; 30.7). Overall, 371 clinical events occurred in 162 children yielding to an incidence rate (IR) of 60.9/100 child-years (CY) [95% confidence interval (CI): 55.1 to 67.2]: 57% of clinical events led to outpatient care (IR: 33/100 CY), 38% to inpatient day care (IR: 22/100 CY), and 10% to hospitalization (IR: 5.9/100 CY). Further medical examinations were made allowing confirmed diagnoses in 40% of those (IR: 22.4/100 CY). Outpatient care was less common among immunodeficient children than those not (relative risk [RR] = 0.32, 95% CI: 0.18 to 0.56), in those whose main caregivers are both parents compared with those who are primarily cared for by their mother only (RR = 0.34, 95% CI: 0.15 to 0.77). CONCLUSION: Untreated HIV-infected children require substantial inpatient and outpatient care in a context where ART is scaling up but still not available to all.
BACKGROUND: We describe health care resource utilization among HIV-1-infectedchildren who have not yet undergone antiretroviral treatment (ART) in Abidjan, Côte d'Ivoire. METHODS:HIV-infectedchildren enrolled prospectively in an HIV care programme in 2 health facilities in Abidjan (2004-2009) were followed up from date of inclusion until database closeout, death, ART initiation, or loss to follow-up (no clinical contact for more than 6 months). Incidences of health care resource utilization (outpatient care, inpatient day care, and hospitalization) were described according to severe morbidity and mixed effect log linear models were computed to identify associated factors. RESULTS: Overall, 405 children were included, entering care at a median age of 4.5 years, 66.9% were receiving cotrimoxazole prophylaxis, and 27.7% met 2006 WHO criteria for immunodeficiency by age. The median follow-up time was 11.6 months (interquartile range: 1.4; 30.7). Overall, 371 clinical events occurred in 162 children yielding to an incidence rate (IR) of 60.9/100 child-years (CY) [95% confidence interval (CI): 55.1 to 67.2]: 57% of clinical events led to outpatient care (IR: 33/100 CY), 38% to inpatient day care (IR: 22/100 CY), and 10% to hospitalization (IR: 5.9/100 CY). Further medical examinations were made allowing confirmed diagnoses in 40% of those (IR: 22.4/100 CY). Outpatient care was less common among immunodeficientchildren than those not (relative risk [RR] = 0.32, 95% CI: 0.18 to 0.56), in those whose main caregivers are both parents compared with those who are primarily cared for by their mother only (RR = 0.34, 95% CI: 0.15 to 0.77). CONCLUSION: Untreated HIV-infectedchildren require substantial inpatient and outpatient care in a context where ART is scaling up but still not available to all.
Authors: C Chintu; G J Bhat; A S Walker; V Mulenga; F Sinyinza; K Lishimpi; L Farrelly; N Kaganson; A Zumla; S H Gillespie; A J Nunn; D M Gibb Journal: Lancet Date: 2004 Nov 20-26 Impact factor: 79.321
Authors: Philimon Gona; Russell B Van Dyke; Paige L Williams; Wayne M Dankner; Miriam C Chernoff; Sharon A Nachman; George R Seage Journal: JAMA Date: 2006-07-19 Impact factor: 56.272
Authors: Stephanie L Sansom; John E Anderson; Paul G Farnham; Kenneth Dominguez; Sada Soorapanth; Jill Clark; Thom Sukalac; Mary Jo Earp; Beverly Bohannon; Mary Glenn Fowler Journal: J Acquir Immune Defic Syndr Date: 2006-04-01 Impact factor: 3.731
Authors: D M Thea; M E St Louis; U Atido; K Kanjinga; B Kembo; M Matondo; T Tshiamala; C Kamenga; F Davachi; C Brown Journal: N Engl J Med Date: 1993-12-02 Impact factor: 91.245
Authors: Veronica Mulenga; Deborah Ford; A Sarah Walker; Darlington Mwenya; James Mwansa; Frederick Sinyinza; Kennedy Lishimpi; Andrew Nunn; Stephen Gillespie; Ali Zumla; Chifumbe Chintu; Diana M Gibb Journal: AIDS Date: 2007-01-02 Impact factor: 4.177
Authors: Besigin Tonwe-Gold; Didier K Ekouevi; Ida Viho; Clarisse Amani-Bosse; Siaka Toure; Patrick A Coffie; François Rouet; Renaud Becquet; Valériane Leroy; Wafaa M El-Sadr; Elaine J Abrams; François Dabis Journal: PLoS Med Date: 2007-08 Impact factor: 11.069